PRESCRIPTION LABELING

Illinois General Assembly - Full Text of HB5327

Select Language

×

The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.

Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.

The English language version is always the official and authoritative version of this website.

NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.

Choose Language

English

Afrikaans

Albanian

Arabic

Armenian

Azerbaijani

Basque

Bengali

Bosnian

Catalan

Croatian

Czech

Danish

Dutch

Esperanto

Estonian

Filipino

Finnish

French

Galician

Georgian

German

Greek

Gujarati

Haitian Creole

Hausa

Hawaiian

Hebrew

Hindi

Hungarian

Icelandic

Indonesian

Interlingua

Interlingue

Inuktitut

Irish

Italian

Japanese

Javanese

Kannada

Khmer

Korean

Latin

Latvian

Lithuanian

Luxembourgish

Macedonian

Malagasy

Malayalam

Maltese

Maori

Marathi

Myanmar

Nepali

Norwegian

Odia

Pashto

Punjabi

Romanian

Russian

Samoan

Sango

Sanskrit

Sardinian

Sindhi

Sinhala

Slovak

Slovenian

Somali

Southern Sotho

Spanish

Sundanese

Swahili

Swedish

Tamil

Telugu

Thai

Tigrinya

Tonga

Turkish

Ukrainian

Urdu

Vietnamese

Welsh

Xhosa

Yiddish

Yoruba

Zulu

Powered by
Translate

Close

Illinois General Assembly

Top Navigation Bar

Translate

Learn

Select General Assembly

Search the 104th General Assembly

Enter search terms for legislation, members, committees, or schedules.

ILGA.GOV

LEGISLATION & LAWS

Bills & Resolutions

Public Acts

Illinois Compiled Statutes

Illinois Constitution

Search Legislation

Glossary

Guide

Reports & Inquiry

Legislative Reports

Special Reports

FTP Site

Legislator Lookup

Capitol Complex Phone Numbers

Rules & Regulations

Illinois Register

Administrative Rules

Senate

Members

Schedules

Committees

Request for Remote Testimony

Journals

Transcripts

Rules

Audio/Video

FOIA Information

Senate Employment Opportunities

Media Guidelines

House

Members

Schedules

Committees

Submit testimony for House Committees

Journals

Transcripts

Rules

Audio/Video

FOIA Information

House Employment Opportunities

Log In

Mobile Top Bar

Search the 104th General Assembly

Enter keywords to search the Illinois General Assembly website.

Full Text of HB5327

Home

Legislation

Full Text

HB5327 - 104th General Assembly

Bill Status

Full Text

Votes

Witness Slips

Select Menu

Bill Status

Full Text

Votes

Witness Slips

Printer Friendly Version

Introduced

Printer Friendly Version

Introduced

Open PDF

104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026
HB5327

Introduced 2/10/2026, by Rep. Mary Beth Canty

SYNOPSIS AS INTRODUCED:

225 ILCS 60/33

from Ch. 111, par. 4400-33
225 ILCS 85/22

from Ch. 111, par. 4142

Amends the Medical Practice Act of 1987. In provisions concerning
legend drugs, provides that, at the request of a person dispensing a drug
or medicine, the label affixed to a box, bottle, vessel, or package
containing mifepristone, misoprostol, or any generic alternative may
include the name of the dispensing health care practice instead of the name
of the person dispensing the drug or medicine. Amends the Pharmacy
Practice Act. In provisions concerning the label of a drug, medicine, or
poison that is lawfully sold or dispensed, provides that, at a
prescriber's request, the label affixed to a box, bottle, vessel, or
package containing mifepristone, misoprostol, or any generic alternative
may include the name of the prescribing health care practice instead of the
name of the prescriber.
LRB104 17984 AAS 31421 b

A BILL FOR

HB5327
LRB104 17984 AAS 31421 b
1

AN ACT concerning regulation.

2

Be it enacted by the People of the State of Illinois,
3
represented in the General Assembly:

4

Section 5.
The Medical Practice Act of 1987 is amended by
5
changing Section 33 as follows:

6

(225 ILCS 60/33)

(from Ch. 111, par. 4400-33)
7

(Section scheduled to be repealed on January 1, 2027)
8

Sec. 33.
Legend drugs.
9

(a) Any person licensed under this Act to practice
10
medicine in all of its branches shall be authorized to
11
purchase legend drugs requiring an order of a person
12
authorized to prescribe drugs, and to dispense such legend
13
drugs in the regular course of practicing medicine. The
14
dispensing of such legend drugs shall be the personal act of
15
the person licensed under this Act and may not be delegated to
16
any other person not licensed under this Act or the Pharmacy
17
Practice Act unless such delegated dispensing functions are
18
under the direct supervision of the physician authorized to
19
dispense legend drugs. Except when dispensing manufacturers'
20
samples or other legend drugs in a maximum 72 hour supply,
21
persons licensed under this Act shall maintain a book or file
22
of prescriptions as required in the Pharmacy Practice Act. Any
23
person licensed under this Act who dispenses any drug or

HB5327
- 2 -
LRB104 17984 AAS 31421 b
1
medicine shall dispense such drug or medicine in good faith
2
and shall affix to the box, bottle, vessel or package
3
containing the same a label indicating (1) the date on which
4
such drug or medicine is dispensed; (2) the name of the
5
patient; (3) the last name of the person dispensing such drug
6
or medicine; (4) the directions for use thereof; and (5) the
7
proprietary name or names or, if there are none, the
8
established name or names of the drug or medicine, the dosage
9
and quantity, except as otherwise authorized by regulation of
10
the Department.
11

(b) The labeling requirements set forth in subsection (a)
12
shall not apply to drugs or medicines in a package which bears
13
a label of the manufacturer containing information describing
14
its contents which is in compliance with requirements of the
15
Federal Food, Drug, and Cosmetic Act and the Illinois Food,
16
Drug, and Cosmetic Act. "Drug" and "medicine" have the
17
meanings ascribed to them in the Pharmacy Practice Act, as now
18
or hereafter amended; "good faith" has the meaning ascribed to
19
it in subsection (u) of Section 102 of the Illinois Controlled
20
Substances Act.
21

(c) Prior to dispensing a prescription to a patient, the
22
physician shall offer a written prescription to the patient
23
which the patient may elect to have filled by the physician or
24
any licensed pharmacy.
25

(d) A violation of any provision of this Section shall
26
constitute a violation of this Act and shall be grounds for

HB5327
- 3 -
LRB104 17984 AAS 31421 b
1
disciplinary action provided for in this Act.
2

(e) Nothing in this Section shall be construed to
3
authorize a chiropractic physician to prescribe drugs.
4

(f) Notwithstanding subsection (a), at the request of the
5
person dispensing a drug or medicine, the label affixed to a
6
box, bottle, vessel, or package containing mifepristone,
7
misoprostol, or any generic alternative may include the name
8
of the dispensing health care practice instead of the name of
9
the person dispensing the drug or medicine.

10
(Source: P.A. 97-622, eff. 11-23-11; 98-1140, eff. 12-30-14
.)

11

Section 10.
The Pharmacy Practice Act is amended by
12
changing Section 22 as follows:

13

(225 ILCS 85/22)

(from Ch. 111, par. 4142)
14

(Section scheduled to be repealed on January 1, 2028)
15

Sec. 22.
Except
as provided in this Section or

only
in the
16
case of a drug, medicine
,
or poison which is lawfully sold or
17
dispensed, at retail, in the original and unbroken package of
18
the manufacturer, packer, or distributor thereof, and which
19
package bears the original label thereon showing the name and
20
address of the manufacturer, packer, or distributor thereof,
21
and the name of the drug, medicine, or poison therein
22
contained, and the directions for its use, no person shall
23
sell or dispense, at retail, any drug, medicine, or poison,
24
without affixing to the box, bottle, vessel, or package

HB5327
- 4 -
LRB104 17984 AAS 31421 b
1
containing the same, a label bearing the name of the article
2
distinctly shown, and the directions for its use, with the
3
name and address of the pharmacy wherein the same is sold or
4
dispensed. However, in the case of a drug, medicine, or poison
5
which is sold or dispensed pursuant to a prescription of a
6
physician licensed to practice medicine in all of its
7
branches, a physician assistant in accordance with subsection
8
(f) of Section 4 of this Act, an advanced practice registered
9
nurse in accordance with subsection (g) of Section 4 of this
10
Act, a licensed dentist, a licensed veterinarian, a licensed
11
podiatric physician, or a licensed optometrist, the label
12
affixed to the box, bottle, vessel, or package containing the
13
same shall show: (a) the name and address of the pharmacy
14
wherein the same is sold or dispensed; (b) the name or initials
15
of the person, authorized to practice pharmacy under the
16
provisions of this Act, selling or dispensing the same, (c)
17
the date on which such prescription was filled; (d) the name of
18
the patient; (e) the serial number of such prescription as
19
filed in the prescription files; (f) the last name of the
20
practitioner who prescribed such prescriptions; (g) the
21
directions for use thereof as contained in such prescription;
22
and (h) the proprietary name or names or the established name
23
or names of the drugs, the dosage and quantity, except as
24
otherwise authorized by rule of the Department.
At a
25
prescriber's request, the label affixed to a box, bottle,
26
vessel, or package containing mifepristone, misoprostol, or

HB5327
- 5 -
LRB104 17984 AAS 31421 b
1
any generic alternative may include the name of the
2
prescribing health care practice instead of the name of the
3
prescriber.

4
(Source: P.A. 100-497, eff. 9-8-17
.)

Footer

Disclaimer

This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.

Contact ILGA Webmaster

ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies

ILGA.GOV

2026 ILGA.gov | All Rights Reserved |
ADA

|
Disclaimers
|
Learn

This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.
Contact ILGA Webmaster

ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies

ILGA.GOV

2026 ILGA.gov | All Rights Reserved |
ADA

|
Disclaimers
|
Learn